34249897|t|Sperm-Specific Glycolysis Enzyme Glyceraldehyde-3-Phosphate Dehydrogenase Regulated by Transcription Factor SOX10 to Promote Uveal Melanoma Tumorigenesis.
34249897|a|Melanoma cells exhibit increased aerobic glycolysis, which represents a major biochemical alteration associated with malignant transformation; thus, glycolytic enzymes could be exploited to selectively target cancer cells in cancer therapy. Sperm-specific glyceraldehyde-3-phosphate dehydrogenase (GAPDHS) switches glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate by coupling with the reduction of NAD+ to NADH. Here, we demonstrated that GAPDHS displays significantly higher expression in uveal melanoma (UM) than in normal controls. Functionally, the knockdown of GAPDHS in UM cell lines hindered glycolysis by decreasing glucose uptake, lactate production, adenosine triphosphate (ATP) generation, cell growth and proliferation; conversely, overexpression of GAPDHS promoted glycolysis, cell growth and proliferation. Furthermore, we identified that SOX10 knockdown reduced the activation of GAPDHS, leading to an attenuated malignant phenotype, and that SOX10 overexpression promoted the activation of GAPDHS, leading to an enhanced malignant phenotype. Mechanistically, SOX10 exerted its function by binding to the promoter of GAPDHS to regulate its expression. Importantly, SOX10 abrogation suppressed in vivo tumor growth and proliferation. Collectively, the results reveal that GAPDHS, which is regulated by SOX10, controls glycolysis and contributes to UM tumorigenesis, highlighting its potential as a therapeutic target.
34249897	33	73	Glyceraldehyde-3-Phosphate Dehydrogenase	Gene	2597
34249897	108	113	SOX10	Gene	6663
34249897	131	153	Melanoma Tumorigenesis	Disease	MESH:D008545
34249897	155	163	Melanoma	Disease	MESH:D008545
34249897	364	370	cancer	Disease	MESH:D009369
34249897	380	386	cancer	Disease	MESH:D009369
34249897	453	459	GAPDHS	Gene	26330
34249897	470	496	glyceraldehyde-3-phosphate	Chemical	MESH:D005986
34249897	500	523	1,3-bisphosphoglycerate	Chemical	MESH:C015891
34249897	558	562	NAD+	Chemical	MESH:D009243
34249897	566	570	NADH	Chemical	MESH:D009243
34249897	599	605	GAPDHS	Gene	26330
34249897	650	664	uveal melanoma	Disease	MESH:C536494
34249897	666	668	UM	Disease	MESH:C536494
34249897	726	732	GAPDHS	Gene	26330
34249897	736	738	UM	Disease	MESH:C536494
34249897	784	791	glucose	Chemical	MESH:D005947
34249897	800	807	lactate	Chemical	MESH:D019344
34249897	820	842	adenosine triphosphate	Chemical	MESH:D000255
34249897	844	847	ATP	Chemical	MESH:D000255
34249897	922	928	GAPDHS	Gene	26330
34249897	1013	1018	SOX10	Gene	6663
34249897	1055	1061	GAPDHS	Gene	26330
34249897	1118	1123	SOX10	Gene	6663
34249897	1166	1172	GAPDHS	Gene	26330
34249897	1235	1240	SOX10	Gene	6663
34249897	1292	1298	GAPDHS	Gene	26330
34249897	1340	1345	SOX10	Gene	6663
34249897	1376	1381	tumor	Disease	MESH:D009369
34249897	1446	1452	GAPDHS	Gene	26330
34249897	1476	1481	SOX10	Gene	6663
34249897	1522	1538	UM tumorigenesis	Disease	MESH:C536494
34249897	Association	MESH:D009243	26330
34249897	Association	MESH:C536494	26330
34249897	Association	MESH:D008545	2597
34249897	Association	MESH:C536494	6663
34249897	Association	MESH:D000255	26330
34249897	Association	MESH:D009369	6663
34249897	Association	2597	6663
34249897	Association	MESH:D019344	26330
34249897	Positive_Correlation	26330	6663
34249897	Association	MESH:C015891	MESH:D005986
34249897	Association	MESH:D008545	6663
34249897	Association	MESH:C015891	MESH:D009243
34249897	Association	MESH:D005986	MESH:D009243

